SIOUXLAND SURGERY CENTER — History
CCN 430089 | 3-year financial timeline | COVID resilience: 58/100
🛡️ Public data only — no PHI permitted on this instance.
$106M
Latest Revenue (FY2022)
+5.6%
Revenue CAGR (3yr)
40.1%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $95M | $104M | $106M | +1.7% | +5.6% |
| Operating Expenses | $57M | $66M | $63M | -3.5% | +5.4% |
| Operating Margin | 39.9% | 37.0% | 40.1% | +8.6% | +0.3% |
| Net Income | $38M | $38M | $42M | +10.4% | +6.0% |
| Licensed Beds | 38 | 38 | 38 | +0.0% | +0.0% |
| Total Patient Days | 2,051 | 1,989 | 2,032 | +2.2% | -0.5% |
| Medicare Day % | 41% | 39% | 38% | -1.5% | -2.9% |
| Medicaid Day % | nan% | 0% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 58/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +11.6% ($95M → $106M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▶ Stable
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+5.6%
This Hospital
+7.6%
State Avg
Latest Margin
40.1%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $111M | 40.3% |
| FY2024 (proj) | $117M | 40.4% |
| FY2025 (proj) | $122M | 40.5% |